The first Mpox test approved by the WHO for use in emergencies

Most recently, the Alinity m MPXV assay received World Health Organization (WHO) authorization to help expand access to Mpox (formerly monkeypox). The change, announced October 3 at a time when the demand for quick and precise testing is ramping up amid an uptick in Mpox cases - especially where outbreaks are happening.

Know More About Mpox And Its Rise To The Top

• Mpox results in severe disease.
• August 2024: WHO declares a public health emergency of Mpox in Africa and its surrounding areas. 
• India: 30 cases as of Wednesday.
• India currently has up 35 labs but lack of facility and Confirmation delays with many African Countries.
• PCR (Polymerase Chain Reaction) is WHO recommended method for diagnosing Mpox.
• Recommended is the Alinity m MPXV test, a real-time PCR test.
• The EUL is important for enabling access to medical tools, and in this case allows a quicker independent review of QIAreach (QIAGENs take on the rapid antigen testing).
• Approval of this test is expected to provide greater testing capacity and faster results from Mpox analysis, which will promote outbreak management and help protect public health.